Valbazen* (Canada)

Manufacturer: Pfizer

albendazole oral suspension U.S.P.

Din 01904779

Veterinary Use Only

Broad-spectrum Dewormer

for cattle

Shake Well Before Using

Medicinal Ingredient

Albendazole, 113.6 mg/mL.

Valbazen* Indications

Broad-spectrum anthelmintic for the treatment of parasitic infections in cattle due to the adult stage of liver flukes (Fasciola hepatica), the adult stage of tapeworms (Moniezia benedeni), gastric worms (the adult stage of Haemonchus placei and Trichostrongylus axei, and the adult, L₄ and inhibited L₄ stage of Ostertagia ostertagi), intestinal worms (adult and L₄ stage of Cooperia oncophora, C. punctata and C. pectinata, and the adult stage of Trichostrongylus colubriformis, Bunostomum phlebotomum, Nematodirus helvetianus, and Oesophagostomum radiatum), and the adult and L₄ stage of lungworms (Dictyocaulus viviparus).

Valbazen* Dosage And Administration

A single oral dose of 4 mL per 45 kg of body weight (equivalent to 10 mg of albendazole per kg), administered using a dosing gun or dose syringe. Under conditions of continued exposure to parasites, retreatment may be required.

The 1 L format contains enough medication to treat 50 x 225 kg animals.

Warning

Treated animals must not be slaughtered for use in food for at least 27 days after the latest treatment with this drug. Because a withdrawal time for milk has not been established, do not use in female dairy cattle of breeding age. Keep out of reach of children.

Valbazen* Caution

Do not administer to female cattle during the first 21 days of pregnancy, or for 21 days after the removal of bulls. Consult your veterinarian for assistance in the diagnosis, treatment, and control of cattle parasitism.

Storage

Store between 15° and 30°C. Protect from freezing (0°C).

Net 1 L

8784

1998 10 09

* Registered trade-mark of Pfizer Products Inc.; Pfizer Canada Inc., licensee.

Pfizer Animal Health, Pfizer Canada Inc., 635 Wilton Grove Road, London, ON N6N 1N7

Nac No.

11981071